Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131

Notice: Undefined offset: 0 in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-content/themes/cri/single.php on line 10

Notice: Trying to get property 'name' of non-object in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-content/themes/cri/single.php on line 10
ASCO20 Preview: Unite & Conquer - Accelerating Progress Together
stdClass Object ( [getLoginUrlResponse] => stdClass Object ( [JSESSIONID] => F3CE8A9ABF087A9C0F5F340CADFDCAA2.app30132b [routing_id] => 00000000.app30132b [url] => https://give.cancerresearch.org/site/CRConsAPI;jsessionid=00000000.app30132b?NONCE_TOKEN=7962798EB35E87F92A32AA09B8631E00 [token] => jIUTzb_POtG3noIxnLKDnPdCXfGEen2qRqxT2D4sLAkDY_DDtS4f6q9pr9CqYxjTcAssgtZYfWabA_hVh3PlA2u3o8zWpToRT-ujp7U ) ) test

Immune to Cancer: The CRI Blog

Subscribe

Share

ASCO20 Preview: Unite & Conquer – Accelerating Progress Together

Arthur N. Brodsky, Ph.D.

Leading up to the kickoff of Cancer Immunotherapy Month in June, the American Society of Clinical Oncology (ASCO) will host its 2020 annual meeting virtually from Friday, May 29 – Sunday, May 31.

Beginning Friday, talks and posters will be available on demand. Particularly relevant at this moment will be the session covering cancer care in the time of COVID. In addition to a talk on COVID-19’s impact on cancer patients, Norman E. Sharpless, M.D., the director of the National Cancer Institute, will speak about efforts to ensure the continued progress of cancer research under these challenging circumstances.

Live presentations start with Saturday morning’s opening session. Soon after, the first day’s focus will shift to novel immunotherapy approaches beyond checkpoint inhibitors, including genetically engineered T cell therapies in patients with advanced solid cancers and a bispecific antibody in multiple myeloma. The role of genomics in improving care for patients with rare cancers will also be discussed, specifically whether it can help doctors pair patients with appropriate treatments, including immunotherapy.

Immunotherapy will also be featured during Sunday’s plenary session, as results from trials in bladder cancer, breast cancer, and colorectal cancer will be unveiled. Additionally, throughout Saturday and Sunday there will be live sessions highlighting the most important advances relating to more than a dozen types of cancer.

For coverage of the latest news coming out of ASCO20, be sure to follow our blog for daily recaps of Saturday and Sunday’s talks, and check out our exciting lineup of Cancer Immunotherapy Month events in June.

Read more:

This site is registered on wpml.org as a development site.